CYCLOPHOSPHAMIDE

CYCLOPHOSPHAMIDE was reported 179390 times

CYCLOPHOSPHAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 143 0.9346
1 THYMUS HYPOPLASIA 144 0.8276
2 HUMAN BOCAVIRUS INFECTION 117 0.6190
3 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1305 0.5913
4 CYSTITIS VIRAL 180 0.4700
5 MANTLE CELL LYMPHOMA RECURRENT 191 0.4391
6 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 408 0.4308
7 B-CELL LYMPHOMA RECURRENT 231 0.4254
8 BLOOD STEM CELL TRANSPLANT FAILURE 90 0.4186
9 VIRAL HAEMORRHAGIC CYSTITIS 294 0.4129
10 ENGRAFTMENT SYNDROME 237 0.4010
11 PRIMARY AMYLOIDOSIS 94 0.3658
12 ENCEPHALITIS CYTOMEGALOVIRUS 159 0.3630
13 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 893 0.3227
14 CYTOMEGALOVIRUS INFECTION REACTIVATION 1398 0.3161
15 ACUTE GRAFT VERSUS HOST DISEASE 1438 0.3138
16 ENGRAFT FAILURE 88 0.3066
17 FOLLICULAR LYMPHOMA 265 0.3011
18 CYSTITIS BACTERIAL 100 0.2959
19 CONGENITAL APLASIA 92 0.2958
20 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 97 0.2957
21 CHRONIC GRAFT VERSUS HOST DISEASE 1057 0.2925
22 CYSTITIS HAEMORRHAGIC 1160 0.2875
23 VENOOCCLUSIVE DISEASE 713 0.2845
24 NOROVIRUS TEST POSITIVE 90 0.2769
25 DISSEMINATED ASPERGILLOSIS 127 0.2691
26 OVARIAN FAILURE 143 0.2673
27 LYMPHOMA TRANSFORMATION 95 0.2639
28 VENOOCCLUSIVE LIVER DISEASE 1288 0.2606
29 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 183 0.2545
30 HUMAN HERPESVIRUS 6 INFECTION 481 0.2542
31 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 357 0.2527
32 HEPATITIS B REACTIVATION 797 0.2509
33 HUMAN POLYOMAVIRUS INFECTION 133 0.2505
34 SECONDARY IMMUNODEFICIENCY 303 0.2494
35 BK VIRUS INFECTION 840 0.2488
36 GRAFT VERSUS HOST DISEASE IN SKIN 547 0.2481
37 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 221 0.2387
38 B-CELL TYPE ACUTE LEUKAEMIA 170 0.2316
39 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 305 0.2316
40 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 485 0.2277
41 NEUROBLASTOMA 87 0.2272
42 HYPOGAMMAGLOBULINAEMIA 1472 0.2238
43 FEBRILE NEUTROPENIA 14787 0.2227
44 DIFFUSE LARGE B-CELL LYMPHOMA 1717 0.2226
45 CYTOMEGALOVIRUS CHORIORETINITIS 433 0.2218
46 EPSTEIN-BARR VIRAEMIA 244 0.2200
47 PLASMA CELL MYELOMA REFRACTORY 294 0.2197
48 ADENOVIRUS INFECTION 622 0.2143
49 FEBRILE BONE MARROW APLASIA 887 0.2085
50 NEUTROPENIC INFECTION 193 0.2017
51 PREMATURE MENOPAUSE 185 0.2002
52 GRAFT VERSUS HOST DISEASE IN LIVER 143 0.1997
53 CYTOKINE RELEASE SYNDROME 3893 0.1939
54 MYELOID LEUKAEMIA 97 0.1936
55 PSEUDOMONAL SEPSIS 338 0.1928
56 CENTRAL NERVOUS SYSTEM LYMPHOMA 261 0.1893
57 GRAFT VERSUS HOST DISEASE 1354 0.1881
58 SYSTEMIC MYCOSIS 218 0.1866
59 PARAINFLUENZAE VIRUS INFECTION 282 0.1852
60 ACUTE PROMYELOCYTIC LEUKAEMIA 190 0.1848
61 JC VIRUS INFECTION 292 0.1825
62 PLASMA CELL LEUKAEMIA 109 0.1817
63 FUSARIUM INFECTION 126 0.1800
64 ENTEROCOCCAL BACTERAEMIA 187 0.1764
65 MYCOBACTERIUM CHELONAE INFECTION 130 0.1759
66 CYTOMEGALOVIRUS VIRAEMIA 778 0.1747
67 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1034 0.1744
68 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 103 0.1740
69 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 302 0.1707
70 NEUTROPENIC SEPSIS 1219 0.1705
71 PNEUMONIA CYTOMEGALOVIRAL 331 0.1703
72 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 439 0.1700
73 HAEMATOTOXICITY 1616 0.1699
74 NEUTROPENIC COLITIS 344 0.1662
75 KLEBSIELLA SEPSIS 187 0.1659
76 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 115 0.1650
77 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 836 0.1641
78 MENINGITIS TUBERCULOUS 91 0.1628
79 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 96 0.1624
80 PNEUMOCYSTIS JIROVECI PNEUMONIA 362 0.1623
81 MYELODYSPLASTIC SYNDROME 2336 0.1613
82 CEREBRAL TOXOPLASMOSIS 150 0.1606
83 PSEUDOMONAL BACTERAEMIA 137 0.1604
84 SECOND PRIMARY MALIGNANCY 1297 0.1558
85 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 144 0.1557
86 INFECTION REACTIVATION 173 0.1511
87 TRANSPLANT FAILURE 369 0.1504
88 ACUTE MYELOID LEUKAEMIA 2342 0.1501
89 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1228 0.1488
90 HEPATITIS B 876 0.1452
91 VIRAEMIA 201 0.1450
92 APLASIA 284 0.1449
93 TUMOUR LYSIS SYNDROME 1264 0.1435
94 CYTOMEGALOVIRUS INFECTION 2335 0.1403
95 GLIOMA 90 0.1400
96 MUCOSAL INFLAMMATION 3668 0.1400
97 EPSTEIN-BARR VIRUS INFECTION 875 0.1399
98 CARDIOTOXICITY 1248 0.1398
99 BRONCHOPULMONARY ASPERGILLOSIS 1071 0.1380
100 TOXOPLASMOSIS 148 0.1370
101 ENTEROBACTER INFECTION 229 0.1361
102 ENTEROCOCCAL SEPSIS 110 0.1358
103 STEM CELL TRANSPLANT 339 0.1355
104 KLEBSIELLA BACTERAEMIA 128 0.1347
105 POLYOMAVIRUS VIRAEMIA 142 0.1337
106 VARICELLA ZOSTER VIRUS INFECTION 277 0.1335
107 PNEUMOCYSTIS JIROVECII INFECTION 159 0.1331
108 CYTOPENIA 1613 0.1316
109 COMPUTERISED TOMOGRAM THORAX ABNORMAL 90 0.1310
110 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 101 0.1292
111 SCEDOSPORIUM INFECTION 91 0.1289
112 LEUKAEMIA RECURRENT 218 0.1288
113 DIFFUSE ALVEOLAR DAMAGE 148 0.1287
114 SYSTEMIC CANDIDA 323 0.1285
115 ASPERGILLUS INFECTION 837 0.1274
116 PERIPHERAL MOTOR NEUROPATHY 178 0.1270
117 MYELOSUPPRESSION 4509 0.1251
118 OBLITERATIVE BRONCHIOLITIS 164 0.1249
119 CANDIDA SEPSIS 112 0.1249
120 ACUTE LYMPHOCYTIC LEUKAEMIA 351 0.1239
121 GRANULOCYTE COUNT DECREASED 228 0.1228
122 PNEUMOCYSTIS JIROVECII PNEUMONIA 1234 0.1228
123 BACTERIAL SEPSIS 394 0.1209
124 LUPUS NEPHRITIS 222 0.1186
125 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 98 0.1163
126 ESCHERICHIA BACTERAEMIA 272 0.1156
127 STENOTROPHOMONAS INFECTION 156 0.1150
128 STREPTOCOCCAL BACTERAEMIA 125 0.1149
129 PNEUMONIA FUNGAL 453 0.1147
130 MUCORMYCOSIS 298 0.1146
131 MANTLE CELL LYMPHOMA 174 0.1142
132 DILATED CARDIOMYOPATHY 113 0.1118
133 ENCEPHALITIS VIRAL 136 0.1117
134 ANAEMIA HAEMOLYTIC AUTOIMMUNE 92 0.1111
135 KLEBSIELLA INFECTION 561 0.1108
136 PLASMACYTOMA 206 0.1106
137 FEBRILE INFECTION 130 0.1105
138 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 88 0.1104
139 ESCHERICHIA SEPSIS 320 0.1103
140 ENTEROCOCCAL INFECTION 533 0.1102
141 HYPOFIBRINOGENAEMIA 108 0.1089
142 CYTOMEGALOVIRUS TEST POSITIVE 194 0.1087
143 THERAPY PARTIAL RESPONDER 1689 0.1082
144 FUNGAEMIA 170 0.1079
145 CYTOGENETIC ABNORMALITY 121 0.1072
146 BONE MARROW TOXICITY 127 0.1072
147 STRONGYLOIDIASIS 173 0.1070
148 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 801 0.1066
149 STAPHYLOCOCCAL BACTERAEMIA 460 0.1057
150 BONE MARROW FAILURE 2126 0.1045
151 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 997 0.1043
152 SUBCLAVIAN VEIN THROMBOSIS 118 0.1036
153 DEVICE RELATED THROMBOSIS 102 0.1034
154 ACUTE MYELOID LEUKAEMIA RECURRENT 222 0.1033
155 PLASMA CELL MYELOMA RECURRENT 335 0.1030
156 ENTEROVIRUS INFECTION 89 0.1030
157 ASPERGILLOSIS 134 0.1025
158 HEPATITIS E 161 0.1019
159 PERIPHERAL SENSORY NEUROPATHY 594 0.1015
160 MICROANGIOPATHY 95 0.1011
161 CAPILLARY LEAK SYNDROME 208 0.1005
162 THROMBOTIC MICROANGIOPATHY 975 0.0999
163 HISTIOCYTOSIS HAEMATOPHAGIC 292 0.0983
164 MYELOPATHY 182 0.0957
165 B-LYMPHOCYTE COUNT DECREASED 130 0.0954
166 B-CELL LYMPHOMA 321 0.0944
167 LYMPHOPENIA 1336 0.0944
168 BLOOD FIBRINOGEN DECREASED 107 0.0937
169 NEOPLASM RECURRENCE 318 0.0937
170 GRANULOMATOSIS WITH POLYANGIITIS 112 0.0928
171 T-CELL LYMPHOMA 106 0.0925
172 STAPHYLOCOCCAL SEPSIS 456 0.0923
173 ENTEROCOLITIS INFECTIOUS 85 0.0921
174 PNEUMATOSIS INTESTINALIS 261 0.0914
175 GENE MUTATION 181 0.0914
176 RHINOVIRUS INFECTION 354 0.0909
177 PNEUMOMEDIASTINUM 162 0.0896
178 ACQUIRED HAEMOPHILIA 87 0.0868
179 LEFT VENTRICULAR DYSFUNCTION 577 0.0861
180 CYTOMEGALOVIRUS COLITIS 197 0.0856
181 CLOSTRIDIUM DIFFICILE COLITIS 906 0.0854
182 ACQUIRED GENE MUTATION 111 0.0847
183 BRAIN ABSCESS 212 0.0837
184 LYMPHOPROLIFERATIVE DISORDER 246 0.0837
185 BACTERAEMIA 987 0.0831
186 PNEUMONIA KLEBSIELLA 152 0.0826
187 PERIPHERAL SENSORIMOTOR NEUROPATHY 103 0.0819
188 NEUROTOXICITY 1426 0.0813
189 APLASTIC ANAEMIA 425 0.0813
190 LEUKOENCEPHALOPATHY 300 0.0805
191 ACINETOBACTER INFECTION 87 0.0795
192 GASTROINTESTINAL TOXICITY 381 0.0792
193 NEUTROPENIA 10780 0.0792
194 PANCYTOPENIA 4426 0.0791
195 BLOOD CULTURE POSITIVE 236 0.0787
196 PSEUDOMONAS INFECTION 675 0.0786
197 NOCARDIOSIS 201 0.0785
198 HERPES SIMPLEX 508 0.0781
199 STEROID DIABETES 117 0.0779
200 CLOSTRIDIUM COLITIS 94 0.0774
201 NEUTROPHIL COUNT DECREASED 3113 0.0763
202 MENINGITIS CRYPTOCOCCAL 133 0.0760
203 SOFT TISSUE INFECTION 139 0.0759
204 RENAL TUBULAR INJURY 92 0.0757
205 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 106 0.0754
206 AUTOIMMUNE HAEMOLYTIC ANAEMIA 252 0.0734
207 SEPTIC SHOCK 3164 0.0726
208 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 168 0.0716
209 OSTEOLYSIS 143 0.0699
210 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1980 0.0698
211 BLOOD LACTATE DEHYDROGENASE INCREASED 1105 0.0697
212 DISEASE PROGRESSION 8229 0.0695
213 BREAST CANCER RECURRENT 219 0.0693
214 VENTRICULAR HYPOKINESIA 222 0.0691
215 JUGULAR VEIN THROMBOSIS 122 0.0685
216 TRANSPLANT DYSFUNCTION 121 0.0677
217 POLYNEUROPATHY 808 0.0674
218 PNEUMONIA PSEUDOMONAL 103 0.0671
219 OTOTOXICITY 124 0.0670
220 CARDIAC DYSFUNCTION 249 0.0668
221 PLASMA CELL MYELOMA 2602 0.0666
222 AGRANULOCYTOSIS 1239 0.0666
223 BONE MARROW DISORDER 201 0.0665
224 AMYLOIDOSIS 113 0.0655
225 DEVICE RELATED SEPSIS 131 0.0650
226 VENOUS THROMBOSIS 253 0.0644
227 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 159 0.0643
228 GASTROENTERITIS NOROVIRUS 85 0.0640
229 METASTASES TO MENINGES 145 0.0637
230 LEUKOPENIA 3157 0.0631
231 EJECTION FRACTION DECREASED 976 0.0627
232 OESOPHAGEAL CANDIDIASIS 250 0.0627
233 OPPORTUNISTIC INFECTION 115 0.0621
234 PNEUMONIA PNEUMOCOCCAL 92 0.0621
235 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 164 0.0616
236 VACCINATION FAILURE 101 0.0607
237 NEUTROPHIL COUNT ABNORMAL 171 0.0604
238 HYPOALBUMINAEMIA 467 0.0600
239 MYELITIS 93 0.0600
240 ORGANISING PNEUMONIA 297 0.0599
241 THROMBOCYTOPENIA 6679 0.0597
242 CHRONIC LYMPHOCYTIC LEUKAEMIA 283 0.0596
243 PARAPARESIS 106 0.0595
244 CARDIOMYOPATHY 875 0.0591
245 PULMONARY ALVEOLAR HAEMORRHAGE 329 0.0586
246 NEPHROPATHY TOXIC 655 0.0583
247 SKIN TOXICITY 329 0.0582
248 LYMPHOCYTE COUNT DECREASED 1027 0.0580
249 CRYPTOCOCCOSIS 93 0.0570
250 HYPOPROTEINAEMIA 108 0.0569
251 LUNG INFILTRATION 495 0.0560
252 ACUTE LEUKAEMIA 90 0.0557
253 HEPATOSPLENOMEGALY 143 0.0557
254 LUNG CONSOLIDATION 155 0.0554
255 BONE MARROW TRANSPLANT 105 0.0553
256 EMPYEMA 110 0.0553
257 PULMONARY TOXICITY 391 0.0552
258 BACTERIAL INFECTION 1031 0.0552
259 INVASIVE DUCTAL BREAST CARCINOMA 149 0.0548
260 ESCHERICHIA INFECTION 449 0.0545
261 SMALL INTESTINAL PERFORATION 102 0.0543
262 BLOOD IMMUNOGLOBULIN G DECREASED 134 0.0540
263 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 204 0.0533
264 VENTRICULAR DYSFUNCTION 136 0.0524
265 VENA CAVA THROMBOSIS 87 0.0523
266 ENCEPHALITIS 362 0.0523
267 PNEUMONIA VIRAL 166 0.0520
268 SEPSIS 5803 0.0520
269 LYMPHOCYTOSIS 110 0.0511
270 CONGESTIVE CARDIOMYOPATHY 210 0.0503
271 LYMPHOMA 778 0.0503
272 MULTIPLE-DRUG RESISTANCE 156 0.0503
273 METASTASIS 359 0.0502
274 COVID-19 PNEUMONIA 592 0.0501
275 ACUTE RESPIRATORY DISTRESS SYNDROME 881 0.0498
276 HYPERBILIRUBINAEMIA 513 0.0495
277 NEUROLOGICAL DECOMPENSATION 114 0.0492
278 PULMONARY HAEMORRHAGE 382 0.0488
279 PSYCHOLOGICAL TRAUMA 421 0.0487
280 TRAUMATIC LUNG INJURY 93 0.0481
281 LYMPHADENOPATHY MEDIASTINAL 92 0.0480
282 METASTASES TO LYMPH NODES 318 0.0471
283 NEOPLASM PROGRESSION 1608 0.0462
284 PNEUMONIA BACTERIAL 418 0.0455
285 HYPERTRIGLYCERIDAEMIA 263 0.0449
286 CANDIDA INFECTION 744 0.0440
287 ILEUS PARALYTIC 196 0.0439
288 LEFT VENTRICULAR FAILURE 150 0.0435
289 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 88 0.0431
290 HEPATOTOXICITY 958 0.0430
291 GRANULOCYTOPENIA 245 0.0430
292 BONE LESION 155 0.0429
293 RESPIRATORY FAILURE 3102 0.0425
294 DIASTOLIC DYSFUNCTION 131 0.0424
295 ENTERITIS 271 0.0423
296 ESCHERICHIA URINARY TRACT INFECTION 180 0.0423
297 PNEUMONITIS 1144 0.0420
298 RECURRENT CANCER 171 0.0419
299 STAPHYLOCOCCUS TEST POSITIVE 88 0.0417
300 RESPIRATORY SYMPTOM 118 0.0414
301 CUSHINGOID 133 0.0414
302 HYPERPYREXIA 175 0.0413
303 HAEMATOLOGICAL INFECTION 101 0.0413
304 SQUAMOUS CELL CARCINOMA OF SKIN 249 0.0412
305 BREAST CANCER METASTATIC 440 0.0409
306 CLOSTRIDIUM TEST POSITIVE 90 0.0408
307 HYPERTRANSAMINASAEMIA 283 0.0406
308 EMBOLISM 334 0.0402
309 HYPERURICAEMIA 164 0.0399
310 WHITE BLOOD CELL COUNT DECREASED 4296 0.0396
311 GROWTH RETARDATION 116 0.0394
312 MULTI-ORGAN FAILURE 681 0.0394
313 DISSEMINATED INTRAVASCULAR COAGULATION 554 0.0393
314 CLOSTRIDIAL INFECTION 133 0.0393
315 GUILLAIN-BARRE SYNDROME 189 0.0390
316 VARICELLA 93 0.0389
317 METASTASES TO BONE 639 0.0389
318 DERMATOMYOSITIS 98 0.0386
319 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 395 0.0384
320 GASTROINTESTINAL NECROSIS 112 0.0384
321 HYPOPHOSPHATAEMIA 283 0.0383
322 GLOMERULONEPHRITIS 93 0.0380
323 CHRONIC SINUSITIS 142 0.0378
324 URINARY TRACT INFECTION BACTERIAL 95 0.0375
325 LUNG OPACITY 99 0.0375
326 APLASIA PURE RED CELL 129 0.0375
327 METASTASES TO LUNG 432 0.0374
328 NEUROPATHY PERIPHERAL 3554 0.0373
329 INTERSTITIAL LUNG DISEASE 1805 0.0372
330 EMBOLISM VENOUS 113 0.0372
331 ENTEROCOLITIS 215 0.0372
332 HAEMOLYTIC URAEMIC SYNDROME 86 0.0371
333 NEPHROTIC SYNDROME 252 0.0367
334 OLIGOHYDRAMNIOS 122 0.0365
335 ATELECTASIS 353 0.0365
336 IMMUNOSUPPRESSION 321 0.0364
337 HAIR DISORDER 299 0.0363
338 LUNG ADENOCARCINOMA 109 0.0362
339 SERUM FERRITIN INCREASED 191 0.0362
340 DEVICE RELATED INFECTION 557 0.0362
341 SPLENOMEGALY 423 0.0361
342 ACUTE HEPATIC FAILURE 493 0.0360
343 IMMUNE THROMBOCYTOPENIA 165 0.0360
344 ACUTE PULMONARY OEDEMA 202 0.0360
345 CANDIDIASIS 144 0.0359
346 PORTAL HYPERTENSION 110 0.0356
347 DISEASE RECURRENCE 1680 0.0353
348 THROMBOTIC THROMBOCYTOPENIC PURPURA 124 0.0352
349 SUSPECTED OFF LABEL USE 158 0.0349
350 DRUG RESISTANCE 896 0.0348
351 PLEURITIC PAIN 96 0.0347
352 LYMPHADENOPATHY 1229 0.0347
353 FOETAL GROWTH RESTRICTION 211 0.0347
354 HYPOXIA 1221 0.0346
355 BRAIN HERNIATION 103 0.0344
356 NECROTISING FASCIITIS 121 0.0343
357 CARDIAC FAILURE ACUTE 227 0.0340
358 VASCULAR DEVICE INFECTION 154 0.0339
359 INTESTINAL PERFORATION 379 0.0337
360 ENCEPHALOPATHY 826 0.0336
361 NECROSIS 186 0.0334
362 THERAPY NON-RESPONDER 1485 0.0330
363 ANAEMIA 6286 0.0329
364 INFECTION 4742 0.0327
365 HYPERVOLAEMIA 161 0.0325
366 HEPATIC NECROSIS 122 0.0324
367 PERICARDIAL EFFUSION 748 0.0323
368 LUNG INFECTION 502 0.0323
369 HERPES VIRUS INFECTION 186 0.0323
370 HEPATIC FUNCTION ABNORMAL 1196 0.0320
371 HEPATIC FAILURE 964 0.0319
372 PLEURAL EFFUSION 1944 0.0319
373 RESPIRATORY SYNCYTIAL VIRUS INFECTION 278 0.0319
374 ASCITES 934 0.0317
375 HEPATITIS FULMINANT 94 0.0316
376 MALIGNANT NEOPLASM PROGRESSION 3230 0.0315
377 METASTASES TO LIVER 553 0.0314
378 ENDOCARDITIS 161 0.0314
379 METASTASES TO CENTRAL NERVOUS SYSTEM 404 0.0313
380 CHRONIC MYELOID LEUKAEMIA 144 0.0312
381 FIBROSIS 94 0.0305
382 ARTHRITIS BACTERIAL 125 0.0304
383 STAPHYLOCOCCAL INFECTION 1003 0.0304
384 PLATELET COUNT DECREASED 3226 0.0302
385 WHITE BLOOD CELL COUNT ABNORMAL 193 0.0302
386 MADAROSIS 351 0.0302
387 GENERALISED OEDEMA 371 0.0299
388 PULMONARY TUBERCULOSIS 128 0.0299
389 HEPATIC LESION 128 0.0296
390 TRANSAMINASES INCREASED 655 0.0294
391 HEPATOMEGALY 289 0.0294
392 MYOCARDITIS 336 0.0293
393 THROMBOPHLEBITIS 102 0.0291
394 HAIR COLOUR CHANGES 362 0.0291
395 RESPIRATORY DISTRESS 796 0.0288
396 FUNGAL INFECTION 959 0.0287
397 PATHOLOGICAL FRACTURE 146 0.0287
398 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1565 0.0285
399 HYPOKALAEMIA 1301 0.0282
400 CACHEXIA 144 0.0280
401 STOMATITIS 1696 0.0279
402 TRANSPLANT REJECTION 223 0.0278
403 NEUROLOGICAL SYMPTOM 158 0.0276
404 BLOOD BILIRUBIN INCREASED 745 0.0276
405 HYDROCEPHALUS 150 0.0275
406 HYDRONEPHROSIS 206 0.0275
407 PYREXIA 9367 0.0270
408 CLOSTRIDIUM DIFFICILE INFECTION 585 0.0268
409 HAIR TEXTURE ABNORMAL 358 0.0267
410 ADRENAL INSUFFICIENCY 323 0.0266
411 VASCULITIS 310 0.0266
412 STREPTOCOCCAL INFECTION 148 0.0266
413 HAEMATOCRIT DECREASED 527 0.0265
414 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 619 0.0265
415 PRODUCT USE IN UNAPPROVED INDICATION 6563 0.0265
416 SINUS TACHYCARDIA 375 0.0264
417 CARDIAC FAILURE 2118 0.0264
418 FACIAL PARESIS 93 0.0263
419 MULTIPLE MYELOMA 122 0.0262
420 DEAFNESS NEUROSENSORY 86 0.0261
421 MENINGITIS 174 0.0260
422 UROSEPSIS 240 0.0260
423 LUNG NEOPLASM 111 0.0260
424 ELECTROLYTE IMBALANCE 301 0.0259
425 CARDIAC TAMPONADE 123 0.0259
426 HAEMODYNAMIC INSTABILITY 197 0.0258
427 C-REACTIVE PROTEIN INCREASED 940 0.0258
428 ILEUS 321 0.0258
429 SQUAMOUS CELL CARCINOMA 243 0.0258
430 CARDIAC FAILURE CHRONIC 110 0.0258
431 HAEMOGLOBIN ABNORMAL 166 0.0258
432 ABDOMINAL ABSCESS 114 0.0258
433 ORAL CANDIDIASIS 339 0.0257
434 HAEMOLYTIC ANAEMIA 230 0.0256
435 ERYSIPELAS 129 0.0256
436 NEOPLASM 295 0.0256
437 CARDIOPULMONARY FAILURE 99 0.0254
438 ACUTE RESPIRATORY FAILURE 486 0.0252
439 HYPOCALCAEMIA 478 0.0252
440 GASTROINTESTINAL PERFORATION 105 0.0252
441 RESPIRATORY TRACT INFECTION 656 0.0252
442 HEPATIC FIBROSIS 86 0.0250
443 PROTEINURIA 476 0.0250
444 COLITIS 939 0.0247
445 OESOPHAGITIS 269 0.0246
446 EXTRAVASATION 101 0.0246
447 SKIN INFECTION 275 0.0245
448 COAGULOPATHY 406 0.0243
449 MYOSITIS 218 0.0243
450 MALNUTRITION 271 0.0242
451 TACHYPNOEA 327 0.0240
452 PAPILLOEDEMA 108 0.0239
453 HAEMOLYSIS 184 0.0238
454 HYPERCALCAEMIA 292 0.0236
455 BRAIN OEDEMA 297 0.0235
456 LOW BIRTH WEIGHT BABY 185 0.0233
457 LARGE INTESTINE PERFORATION 161 0.0232
458 PYELONEPHRITIS 199 0.0229
459 PATHOGEN RESISTANCE 208 0.0228
460 MITRAL VALVE INCOMPETENCE 257 0.0227
461 ALANINE AMINOTRANSFERASE INCREASED 1394 0.0227
462 TROPONIN INCREASED 172 0.0226
463 BRONCHIECTASIS 152 0.0225
464 MENINGITIS ASEPTIC 101 0.0225
465 RENAL CELL CARCINOMA 110 0.0225
466 INTRACRANIAL PRESSURE INCREASED 124 0.0222
467 ODYNOPHAGIA 132 0.0221
468 HAEMORRHAGE INTRACRANIAL 328 0.0219
469 LEUKOCYTOSIS 396 0.0219
470 METABOLIC DISORDER 127 0.0218
471 METASTATIC NEOPLASM 94 0.0218
472 PROCTALGIA 140 0.0218
473 HAEMATURIA 743 0.0217
474 PNEUMOTHORAX 344 0.0217
475 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 108 0.0217
476 RED CELL DISTRIBUTION WIDTH INCREASED 90 0.0216
477 NEUTROPHIL COUNT INCREASED 221 0.0216
478 HEPATIC CYTOLYSIS 275 0.0215
479 BLOOD DISORDER 172 0.0214
480 ASPARTATE AMINOTRANSFERASE INCREASED 1139 0.0214
481 OSTEONECROSIS 700 0.0213
482 HYPOMAGNESAEMIA 293 0.0210
483 HERPES ZOSTER 1207 0.0210
484 PERFORMANCE STATUS DECREASED 98 0.0210
485 STRESS CARDIOMYOPATHY 122 0.0210
486 PNEUMONIA 6779 0.0209
487 OLIGURIA 129 0.0208
488 RETINAL HAEMORRHAGE 148 0.0208
489 HYPERGLYCAEMIA 752 0.0206
490 DRUG TOXICITY 281 0.0206
491 ABDOMINAL TENDERNESS 102 0.0205
492 GASTROINTESTINAL INFLAMMATION 160 0.0204
493 LIVER INJURY 494 0.0201
494 DRUG-INDUCED LIVER INJURY 629 0.0200
495 GASTROINTESTINAL INFECTION 179 0.0199
496 SHOCK HAEMORRHAGIC 162 0.0199
497 ORAL DISORDER 145 0.0198
498 BASAL CELL CARCINOMA 307 0.0197
499 CARDIOGENIC SHOCK 282 0.0196
500 PULMONARY FIBROSIS 376 0.0196
501 LEUKAEMIA 184 0.0195
502 GAMMA-GLUTAMYLTRANSFERASE INCREASED 430 0.0194
503 INFLAMMATORY MARKER INCREASED 96 0.0193
504 DEEP VEIN THROMBOSIS 1258 0.0193
505 SMALL INTESTINAL OBSTRUCTION 238 0.0193
506 HEPATIC ENCEPHALOPATHY 180 0.0193
507 TRICUSPID VALVE INCOMPETENCE 153 0.0192
508 CEREBRAL ISCHAEMIA 99 0.0192
509 HYPONATRAEMIA 1083 0.0192
510 OFF LABEL USE 16826 0.0192
511 HAEMOGLOBIN DECREASED 1964 0.0191
512 MYOPATHY 164 0.0190
513 VIRAL INFECTION 631 0.0189
514 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 96 0.0189
515 SARCOIDOSIS 90 0.0189
516 ATRIAL FLUTTER 151 0.0189
517 PREMATURE BABY 567 0.0188
518 ACUTE CORONARY SYNDROME 156 0.0188
519 HEMIPARESIS 319 0.0188
520 HYPOVOLAEMIA 110 0.0188
521 TOXIC ENCEPHALOPATHY 95 0.0187
522 CHOLECYSTITIS ACUTE 106 0.0187
523 ACUTE KIDNEY INJURY 2843 0.0186
524 CHOLECYSTITIS 221 0.0185
525 FACIAL PARALYSIS 157 0.0184
526 HEPATITIS 471 0.0184
527 PULMONARY HYPERTENSION 382 0.0183
528 PULMONARY MASS 273 0.0183
529 INTENTIONAL PRODUCT USE ISSUE 1600 0.0182
530 PULMONARY EMBOLISM 1733 0.0182
531 ATAXIA 216 0.0182
532 ANAL ABSCESS 98 0.0182
533 CHOLESTASIS 349 0.0182
534 HYPOVOLAEMIC SHOCK 87 0.0181
535 PLATELET COUNT ABNORMAL 109 0.0180
536 TOXIC EPIDERMAL NECROLYSIS 272 0.0179
537 LYMPHOEDEMA 123 0.0178
538 SKIN NECROSIS 92 0.0177
539 NASAL POLYPS 87 0.0177
540 BLOOD ALBUMIN DECREASED 140 0.0176
541 NERVOUS SYSTEM DISORDER 550 0.0176
542 CORONAVIRUS INFECTION 116 0.0175
543 ANGIOPATHY 98 0.0175
544 BLOOD LACTIC ACID INCREASED 91 0.0173
545 END STAGE RENAL DISEASE 315 0.0173
546 CELLULITIS 868 0.0172
547 PULMONARY ARTERIAL HYPERTENSION 248 0.0171
548 APPENDICITIS 159 0.0170
549 MOUTH ULCERATION 358 0.0170
550 FAILURE TO THRIVE 88 0.0169
551 GASTROENTERITIS 247 0.0169
552 GINGIVITIS 91 0.0169
553 RALES 97 0.0167
554 STATUS EPILEPTICUS 188 0.0166
555 PETECHIAE 173 0.0166
556 HAEMODIALYSIS 139 0.0165
557 SUPRAVENTRICULAR TACHYCARDIA 158 0.0165
558 SUBDURAL HAEMATOMA 236 0.0165
559 TREATMENT FAILURE 1365 0.0165
560 SKIN MASS 109 0.0163
561 PREMATURE DELIVERY 258 0.0162
562 BONE PAIN 942 0.0161
563 RENAL IMPAIRMENT 1347 0.0160
564 RENAL TUBULAR NECROSIS 156 0.0159
565 MASS 221 0.0158
566 IMMUNODEFICIENCY 235 0.0157
567 ACIDOSIS 120 0.0157
568 BODY TEMPERATURE INCREASED 319 0.0156
569 RENAL FAILURE 2067 0.0156
570 HEPATIC STEATOSIS 289 0.0155
571 PURPURA 136 0.0154
572 PULMONARY OEDEMA 687 0.0153
573 PANCREATITIS ACUTE 341 0.0152
574 HEPATOCELLULAR INJURY 215 0.0151
575 MENTAL STATUS CHANGES 419 0.0151
576 ATRIAL FIBRILLATION 1469 0.0151
577 PROTHROMBIN TIME PROLONGED 90 0.0150
578 LUNG DISORDER 735 0.0150
579 RIGHT VENTRICULAR FAILURE 105 0.0150
580 TYPE 1 DIABETES MELLITUS 90 0.0149
581 HEPATITIS CHOLESTATIC 90 0.0149
582 BLOOD URIC ACID INCREASED 86 0.0149
583 EOSINOPHIL COUNT INCREASED 124 0.0149
584 SHOCK 341 0.0148
585 SUDDEN DEATH 156 0.0147
586 BLOOD ALKALINE PHOSPHATASE INCREASED 366 0.0147
587 APHASIA 442 0.0146
588 LIPASE INCREASED 112 0.0146
589 CONCOMITANT DISEASE AGGRAVATED 90 0.0146
590 GENERAL PHYSICAL HEALTH DETERIORATION 1685 0.0145
591 NO THERAPEUTIC RESPONSE 176 0.0144
592 UPPER RESPIRATORY TRACT INFECTION 666 0.0144
593 BLOOD CREATININE INCREASED 941 0.0144
594 COVID-19 2526 0.0144
595 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 87 0.0143
596 OSTEONECROSIS OF JAW 352 0.0142
597 GENERALISED TONIC-CLONIC SEIZURE 235 0.0142
598 SKIN LESION 388 0.0141
599 HYPOPHAGIA 361 0.0141
600 HYPOTENSION 2831 0.0141
601 ORAL HERPES 275 0.0141
602 CARDIOMEGALY 173 0.0141
603 ANURIA 121 0.0140
604 NAIL DISORDER 123 0.0140
605 CIRCULATORY COLLAPSE 239 0.0140
606 IMPAIRED QUALITY OF LIFE 201 0.0140
607 INFUSION RELATED REACTION 926 0.0140
608 GASTROINTESTINAL DISORDER 1246 0.0139
609 MALIGNANT MELANOMA 186 0.0139
610 TACHYCARDIA 1233 0.0139
611 HYPOTHYROIDISM 441 0.0138
612 RASH MACULO-PAPULAR 305 0.0137
613 PERICARDITIS 228 0.0136
614 TRANSFUSION 142 0.0135
615 RENAL CYST 107 0.0135
616 UPPER GASTROINTESTINAL HAEMORRHAGE 226 0.0134
617 DECUBITUS ULCER 108 0.0132
618 TOXIC SKIN ERUPTION 132 0.0131
619 HYPERTHERMIA 100 0.0131
620 CEREBRAL INFARCTION 320 0.0131
621 SENSORY LOSS 105 0.0130
622 URINE OUTPUT DECREASED 114 0.0130
623 OEDEMA 705 0.0130
624 MYOCARDIAL ISCHAEMIA 146 0.0128
625 TUBULOINTERSTITIAL NEPHRITIS 239 0.0127
626 WHITE BLOOD CELL COUNT INCREASED 488 0.0127
627 NODULE 165 0.0126
628 CENTRAL NERVOUS SYSTEM LESION 172 0.0125
629 LOWER RESPIRATORY TRACT INFECTION 568 0.0125
630 OSTEOMYELITIS 226 0.0125
631 SUBARACHNOID HAEMORRHAGE 127 0.0125
632 LIVER DISORDER 552 0.0124
633 ABSCESS 198 0.0124
634 OBSTRUCTIVE AIRWAYS DISORDER 138 0.0124
635 RENAL FAILURE ACUTE 521 0.0123
636 CEREBRAL HAEMORRHAGE 437 0.0122
637 TOXICITY TO VARIOUS AGENTS 2050 0.0121
638 PULMONARY CONGESTION 159 0.0120
639 HEMIPLEGIA 100 0.0120
640 RESPIRATORY DISORDER 359 0.0120
641 VENTRICULAR EXTRASYSTOLES 124 0.0119
642 CHILLS 1397 0.0119
643 RHINITIS 96 0.0119
644 HEPATITIS C 143 0.0118
645 LOWER GASTROINTESTINAL HAEMORRHAGE 87 0.0118
646 TENDERNESS 122 0.0117
647 PERITONITIS 242 0.0117
648 GASTROINTESTINAL HAEMORRHAGE 968 0.0116
649 RED BLOOD CELL COUNT DECREASED 331 0.0116
650 DRUG INTOLERANCE 1116 0.0115
651 SPINAL COMPRESSION FRACTURE 95 0.0115
652 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 335 0.0114
653 FLUID OVERLOAD 166 0.0114
654 FULL BLOOD COUNT DECREASED 229 0.0114
655 OBESITY 181 0.0113
656 JAUNDICE 305 0.0113
657 ORAL PAIN 253 0.0113
658 PNEUMONIA ASPIRATION 282 0.0113
659 ISCHAEMIC STROKE 199 0.0111
660 PHARYNGITIS 137 0.0110
661 ACUTE MYOCARDIAL INFARCTION 324 0.0110
662 BLOOD UREA INCREASED 183 0.0109
663 ALTERED STATE OF CONSCIOUSNESS 236 0.0109
664 THERAPEUTIC RESPONSE DECREASED 660 0.0109
665 ALOPECIA 2136 0.0109
666 DEPRESSED LEVEL OF CONSCIOUSNESS 427 0.0108
667 ANOREXIA 139 0.0108
668 HYPERKALAEMIA 378 0.0108
669 ORTHOSTATIC HYPOTENSION 187 0.0107
670 ARRHYTHMIA 505 0.0107
671 HAEMOPTYSIS 297 0.0106
672 VOMITING 5000 0.0106
673 HYPOTONIA 105 0.0105
674 CYSTITIS 330 0.0104
675 SKIN HYPERPIGMENTATION 89 0.0103
676 VENTRICULAR FIBRILLATION 115 0.0103
677 DYSPNOEA EXERTIONAL 387 0.0103
678 REBOUND EFFECT 116 0.0103
679 GLOMERULAR FILTRATION RATE DECREASED 126 0.0102
680 CARDIAC ARREST 846 0.0102
681 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113 0.0102
682 RESPIRATORY RATE INCREASED 90 0.0101
683 HAEMORRHOIDS 197 0.0101
684 PLATELET COUNT INCREASED 131 0.0100
685 ASPIRATION 110 0.0100
686 VENTRICULAR TACHYCARDIA 165 0.0100
687 GASTRIC ULCER 189 0.0099
688 TOOTH ABSCESS 101 0.0099
689 MOTOR DYSFUNCTION 101 0.0099
690 DEAFNESS 259 0.0099
691 SKIN ULCER 256 0.0099
692 SPINAL PAIN 116 0.0099
693 DYSPHAGIA 939 0.0099
694 GRAND MAL CONVULSION 91 0.0098
695 DIARRHOEA HAEMORRHAGIC 92 0.0098
696 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 699 0.0098
697 ABDOMINAL PAIN 2284 0.0098
698 NEPHROPATHY 91 0.0097
699 FLANK PAIN 91 0.0097
700 DEHYDRATION 1294 0.0097
701 EPILEPSY 296 0.0097
702 DELIRIUM 334 0.0096
703 BLOOD SODIUM DECREASED 181 0.0096
704 SENSORY DISTURBANCE 154 0.0096
705 SPUTUM DISCOLOURED 89 0.0094
706 DRUG ERUPTION 166 0.0094
707 ERYTHEMA MULTIFORME 87 0.0093
708 SEIZURE 1074 0.0093
709 DECREASED APPETITE 2159 0.0093
710 DRUG EXPOSURE DURING PREGNANCY 316 0.0093
711 PRODUCTIVE COUGH 439 0.0092
712 HAEMATEMESIS 232 0.0091
713 CARDIAC FAILURE CONGESTIVE 734 0.0091
714 EYELID PTOSIS 92 0.0090
715 GASTRIC HAEMORRHAGE 104 0.0090
716 ABORTION INDUCED 85 0.0090
717 COGNITIVE DISORDER 421 0.0090
718 SYNCOPE 899 0.0090
719 URINARY TRACT INFECTION 1527 0.0089
720 MELAENA 197 0.0089
721 PANCREATITIS 470 0.0089
722 HYPOTHERMIA 90 0.0089
723 GASTRITIS 232 0.0088
724 LIVER FUNCTION TEST ABNORMAL 255 0.0088
725 DYSARTHRIA 330 0.0088
726 EPISTAXIS 650 0.0087
727 AMENORRHOEA 152 0.0087
728 DIARRHOEA 5568 0.0086
729 METABOLIC ACIDOSIS 272 0.0085
730 ASTHENIA 3191 0.0085
731 OEDEMA PERIPHERAL 1028 0.0084
732 CONDITION AGGRAVATED 2559 0.0084
733 ELECTROCARDIOGRAM QT PROLONGED 302 0.0084
734 HYPERTENSION 1775 0.0084
735 HAEMATOMA 217 0.0084
736 BONE DISORDER 152 0.0083
737 MATERNAL EXPOSURE DURING PREGNANCY 740 0.0083
738 BLINDNESS 337 0.0083
739 OSTEOPOROSIS 338 0.0082
740 FOETAL EXPOSURE DURING PREGNANCY 667 0.0082
741 PRODUCT USE ISSUE 1539 0.0082
742 DRUG INEFFECTIVE 10788 0.0082
743 INFLAMMATION 422 0.0082
744 NIGHT SWEATS 263 0.0082
745 CONSTIPATION 1752 0.0080
746 NAUSEA 6354 0.0080
747 CARDIO-RESPIRATORY ARREST 335 0.0080
748 BRADYCARDIA 424 0.0080
749 EOSINOPHILIA 140 0.0080
750 CONJUNCTIVITIS 148 0.0080
751 THROMBOSIS 639 0.0079
752 OXYGEN SATURATION DECREASED 446 0.0079
753 MUSCULAR WEAKNESS 894 0.0079
754 HYPERLIPIDAEMIA 94 0.0079
755 ULCER 125 0.0078
756 HEPATIC CIRRHOSIS 146 0.0078
757 SKIN REACTION 109 0.0077
758 TOOTH INFECTION 102 0.0077
759 BLOOD CALCIUM DECREASED 87 0.0077
760 DYSURIA 284 0.0077
761 PARALYSIS 110 0.0077
762 DERMATITIS 161 0.0077
763 NEURALGIA 186 0.0076
764 PALLOR 208 0.0076
765 DIPLOPIA 198 0.0076
766 MUSCULOSKELETAL CHEST PAIN 117 0.0076
767 TASTE DISORDER 152 0.0075
768 DIVERTICULITIS 207 0.0075
769 HYPERTHYROIDISM 108 0.0075
770 COUGH 2082 0.0074
771 LIVER FUNCTION TEST INCREASED 159 0.0074
772 HEPATIC ENZYME INCREASED 502 0.0074
773 GOUT 132 0.0073
774 DIALYSIS 104 0.0073
775 ILL-DEFINED DISORDER 441 0.0073
776 DRUG LEVEL INCREASED 120 0.0072
777 UNRESPONSIVE TO STIMULI 186 0.0072
778 COLON CANCER 107 0.0072
779 ANAPHYLACTIC REACTION 396 0.0072
780 SKIN DISORDER 239 0.0072
781 PRODUCT PRESCRIBING ISSUE 155 0.0071
782 IMMUNE SYSTEM DISORDER 92 0.0070
783 COMA 331 0.0069
784 CYANOSIS 109 0.0069
785 CONVULSION 394 0.0069
786 URINARY RETENTION 229 0.0069
787 CONFUSIONAL STATE 1101 0.0068
788 DYSPNOEA 3852 0.0068
789 BLOOD POTASSIUM DECREASED 204 0.0068
790 HYPOKINESIA 97 0.0067
791 HAEMORRHAGE 697 0.0067
792 STEVENS-JOHNSON SYNDROME 147 0.0066
793 SARS-COV-2 TEST POSITIVE 87 0.0066
794 DISORIENTATION 261 0.0066
795 FACE OEDEMA 111 0.0066
796 INTESTINAL OBSTRUCTION 248 0.0066
797 BRONCHOSPASM 93 0.0065
798 DRUG INTERACTION 1023 0.0064
799 RENAL DISORDER 297 0.0064
800 LETHARGY 365 0.0063
801 SPINAL FRACTURE 127 0.0063
802 NEOPLASM MALIGNANT 421 0.0063
803 CARDIOVASCULAR DISORDER 159 0.0063
804 PAIN IN JAW 177 0.0062
805 ANGINA PECTORIS 179 0.0062
806 BLOOD COUNT ABNORMAL 94 0.0062
807 OSTEOPENIA 94 0.0062
808 DEATH 5288 0.0061
809 FEEDING DISORDER 120 0.0059
810 CHEST PAIN 1094 0.0059
811 URINARY INCONTINENCE 173 0.0058
812 BLOOD TRIGLYCERIDES INCREASED 103 0.0058
813 CHEST DISCOMFORT 589 0.0057
814 OROPHARYNGEAL PAIN 531 0.0057
815 EXPOSURE DURING PREGNANCY 355 0.0057
816 PARAESTHESIA 895 0.0057
817 RECTAL HAEMORRHAGE 244 0.0057
818 SINUSITIS 582 0.0057
819 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 146 0.0057
820 LACRIMATION INCREASED 171 0.0057
821 DIABETES MELLITUS 425 0.0056
822 VISUAL ACUITY REDUCED 184 0.0055
823 EAR PAIN 107 0.0055
824 FATIGUE 4284 0.0055
825 LUNG NEOPLASM MALIGNANT 226 0.0055
826 LACTIC ACIDOSIS 178 0.0055
827 MYALGIA 932 0.0055
828 CARDIAC DISORDER 512 0.0055
829 BLOOD PRESSURE DECREASED 362 0.0054
830 SYSTEMIC LUPUS ERYTHEMATOSUS 193 0.0054
831 BACK PAIN 1246 0.0054
832 BREAST CANCER 495 0.0053
833 RASH ERYTHEMATOUS 252 0.0053
834 INFLUENZA 584 0.0052
835 RHINORRHOEA 336 0.0052
836 HYPOAESTHESIA 775 0.0052
837 ABDOMINAL DISTENSION 539 0.0052
838 CATARACT 305 0.0051
839 WEIGHT DECREASED 1426 0.0051
840 TOOTHACHE 91 0.0050
841 RASH PAPULAR 112 0.0050
842 BLOOD PRESSURE SYSTOLIC INCREASED 97 0.0050
843 RIB FRACTURE 101 0.0049
844 SLEEP APNOEA SYNDROME 92 0.0048
845 ANAPHYLACTIC SHOCK 121 0.0047
846 RASH 2044 0.0047
847 PRESYNCOPE 114 0.0047
848 TRANSIENT ISCHAEMIC ATTACK 158 0.0047
849 MUSCULOSKELETAL PAIN 245 0.0047
850 BRONCHITIS 346 0.0047
851 CONTRAINDICATED PRODUCT ADMINISTERED 141 0.0047
852 HYPERSENSITIVITY 863 0.0046
853 HAEMATOCHEZIA 253 0.0046
854 IMPAIRED HEALING 150 0.0046
855 POST PROCEDURAL COMPLICATION 87 0.0045
856 DRUG EFFECT INCOMPLETE 162 0.0045
857 CHRONIC KIDNEY DISEASE 338 0.0044
858 WHEEZING 262 0.0044
859 EATING DISORDER 94 0.0044
860 LABORATORY TEST ABNORMAL 129 0.0044
861 INTERNATIONAL NORMALISED RATIO INCREASED 123 0.0043
862 POLLAKIURIA 179 0.0043
863 DISCOMFORT 261 0.0043
864 MENTAL DISORDER 183 0.0042
865 SPEECH DISORDER 219 0.0042
866 CHOLELITHIASIS 135 0.0041
867 RENAL INJURY 122 0.0041
868 LOSS OF CONSCIOUSNESS 522 0.0041
869 ERYTHEMA 830 0.0040
870 ABDOMINAL PAIN LOWER 102 0.0040
871 FLUID RETENTION 203 0.0040
872 DISTURBANCE IN ATTENTION 215 0.0040
873 ADVERSE EVENT 366 0.0040
874 TREMOR 655 0.0039
875 RESPIRATORY ARREST 106 0.0038
876 THROAT TIGHTNESS 104 0.0038
877 HEADACHE 2407 0.0038
878 BLOOD CREATINE PHOSPHOKINASE INCREASED 110 0.0038
879 HEART RATE INCREASED 373 0.0038
880 PSYCHOTIC DISORDER 111 0.0038
881 BLISTER 211 0.0038
882 DIABETIC KETOACIDOSIS 90 0.0037
883 NECK PAIN 205 0.0037
884 HYPOGLYCAEMIA 177 0.0036
885 AGITATION 266 0.0036
886 DYSPEPSIA 351 0.0036
887 TINNITUS 163 0.0035
888 MALAISE 1522 0.0035
889 GASTRIC CANCER 87 0.0034
890 SKIN EXFOLIATION 289 0.0034
891 PAIN 2085 0.0034
892 TYPE 2 DIABETES MELLITUS 113 0.0034
893 ARTHRALGIA 1391 0.0033
894 HYPOACUSIS 144 0.0033
895 PAIN IN EXTREMITY 985 0.0033
896 GASTROOESOPHAGEAL REFLUX DISEASE 268 0.0033
897 ABDOMINAL PAIN UPPER 679 0.0033
898 PALPITATIONS 385 0.0033
899 LIMB DISCOMFORT 101 0.0033
900 RHABDOMYOLYSIS 136 0.0033
901 DYSGEUSIA 242 0.0033
902 DYSSTASIA 95 0.0033
903 CEREBROVASCULAR ACCIDENT 551 0.0032
904 SWELLING FACE 211 0.0032
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 169 0.0032
906 NASAL CONGESTION 183 0.0031
907 DYSPHONIA 182 0.0031
908 TREATMENT NONCOMPLIANCE 168 0.0031
909 HYPERHIDROSIS 394 0.0031
910 MYOCARDIAL INFARCTION 533 0.0031
911 CORONARY ARTERY DISEASE 90 0.0030
912 DIZZINESS 1449 0.0029
913 RASH PRURITIC 157 0.0029
914 ASTHMA 324 0.0029
915 MOVEMENT DISORDER 92 0.0029
916 PROSTATE CANCER 230 0.0029
917 SLEEP DISORDER 201 0.0028
918 UNEVALUABLE EVENT 203 0.0027
919 VERTIGO 163 0.0027
920 VISUAL IMPAIRMENT 331 0.0027
921 WEIGHT INCREASED 596 0.0027
922 VISION BLURRED 365 0.0027
923 GAIT DISTURBANCE 506 0.0026
924 OSTEOARTHRITIS 112 0.0026
925 INFLUENZA LIKE ILLNESS 217 0.0026
926 SWELLING 244 0.0026
927 SOMNOLENCE 522 0.0026
928 EMOTIONAL DISTRESS 308 0.0025
929 HOT FLUSH 187 0.0025
930 SKIN DISCOLOURATION 114 0.0025
931 INSOMNIA 659 0.0025
932 DEPRESSION 560 0.0025
933 ANXIETY 698 0.0025
934 FALL 816 0.0024
935 MEMORY IMPAIRMENT 333 0.0024
936 ABDOMINAL DISCOMFORT 404 0.0024
937 RESTLESSNESS 87 0.0024
938 ARTHROPATHY 131 0.0024
939 MUSCULOSKELETAL STIFFNESS 204 0.0023
940 ANGIOEDEMA 102 0.0023
941 MOBILITY DECREASED 165 0.0023
942 ARTHRITIS 180 0.0023
943 ADVERSE DRUG REACTION 203 0.0023
944 BLOOD PRESSURE INCREASED 345 0.0023
945 DRY MOUTH 183 0.0023
946 DEPRESSED MOOD 119 0.0022
947 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
948 PERIPHERAL SWELLING 344 0.0022
949 DRY EYE 111 0.0022
950 THERAPEUTIC PRODUCT EFFECT DECREASED 99 0.0022
951 BALANCE DISORDER 191 0.0022
952 DYSKINESIA 89 0.0022
953 NO ADVERSE EVENT 393 0.0022
954 FLUSHING 220 0.0022
955 ABORTION SPONTANEOUS 86 0.0021
956 MUSCLE SPASMS 390 0.0021
957 PRURITUS 805 0.0021
958 VAGINAL HAEMORRHAGE 90 0.0021
959 NEPHROLITHIASIS 94 0.0020
960 HALLUCINATION 154 0.0020
961 NASOPHARYNGITIS 372 0.0020
962 URTICARIA 338 0.0020
963 JOINT SWELLING 236 0.0020
964 CONTUSION 181 0.0019
965 EYE PAIN 103 0.0018
966 AMNESIA 118 0.0018
967 ILLNESS 182 0.0018
968 ECZEMA 92 0.0018
969 FEELING HOT 106 0.0017
970 UNDERDOSE 125 0.0017
971 RHEUMATOID ARTHRITIS 193 0.0017
972 HOSPITALISATION 257 0.0017
973 MEDICATION ERROR 91 0.0016
974 BLADDER CANCER 95 0.0016
975 BURNING SENSATION 113 0.0016
976 IRRITABILITY 88 0.0015
977 THERAPY INTERRUPTED 103 0.0014
978 BLOOD GLUCOSE INCREASED 263 0.0014
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 240 0.0013
980 INJURY 92 0.0013
981 DRY SKIN 164 0.0012
982 OVERDOSE 250 0.0012
983 FEELING ABNORMAL 262 0.0011
984 MIGRAINE 101 0.0011
985 SUICIDAL IDEATION 89 0.0010
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 120 0.0006
987 PRODUCT DOSE OMISSION ISSUE 136 0.0005
988 INJECTION SITE PAIN 89 0.0003